LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of human IGF-1 to treat cardiac disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of human protein C for prevention and treatment of depositio

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of hydrophobic crosslinking agents to prepare...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of hyperpolymeric hemoglobin for the treatment of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of hypersensitive response elicitor protein or...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of IGF-1

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of IGF-BP for refolding of IGF

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of IGF-I for the treatment of kidney disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of IGF-I for the treatment of renal insufficiencies, steriod

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of IL-18 inhibitors for treating head injuries

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of immunosuppressants for MMP mediated diseases

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of INHIB (the C3 .beta.-chain) in the detection and inhibiti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of inhibitors of enzymes having activities of amino...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of inhibitors of protein kinase C epsilon to treat pain

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of inhibitors of protein kinase C epsilon to treat pain

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of insulin and IGF-1

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of insulin and IGF-I

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of insulin for the treatment of cartilagenous disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Use of insulin for the treatment of cartilaginous disorders